Leelyn Smith’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-473
Closed -$220K 138
2024
Q3
$220K Sell
473
-5
-1% -$2.4K 0.04% 121
2024
Q2
$224K Sell
478
-13
-3% -$5.64K 0.04% 117
2024
Q1
$205K Buy
+491
New +$208K 0.04% 124
2023
Q3
Sell
-853
Closed -$300K 119
2023
Q2
$300K Sell
853
-172
-17% -$58K 0.07% 103
2023
Q1
$323K Sell
1,025
-840
-45% -$252K 0.08% 102
2022
Q4
$303K Buy
1,865
+1,049
+129% +$320K 0.08% 103
2022
Q3
$236K Sell
816
-1,826
-69% -$525K 0.08% 99
2022
Q2
$744K Sell
2,642
-2,254
-46% -$603K 0.19% 82
2022
Q1
$1.28M Buy
4,896
+146
+3% +$34.6K 0.33% 69
2021
Q4
$1.04M Buy
4,750
+551
+13% +$107K 0.28% 78
2021
Q3
$762K Buy
4,199
+69
+2% +$13.5K 0.22% 81
2021
Q2
$833K Sell
4,130
-587
-12% -$123K 0.25% 78
2021
Q1
$1.01M Buy
+4,717
New +$1.04M 0.3% 77

Other funds holding VRTX